Randomized phase 2a trial assessing a novel septin molecular glue in Alzheimer's disease.
Nuytten M, Voets M, Debroux E, Princen K, Pringels L, Fivaz M, Byl E, Ramael S, De Witte K, Boada M, Morató X, Tartari JP, Lafuente A, Macias EF, Matias-Guiu JA, Vijverberg E, Teunissen CE, Anderer P, Staggs V, Hayman V, Corbett A, Ballard C, Harrison JE, Windisch M, Westman AB, Zetterberg H, Dickson S, Mallinckrodt C, Hendrix S, Cummings J, Griffioen G.
Nuytten M, et al. Among authors: westman ab.
Alzheimers Dement. 2025 Sep;21(9):e70537. doi: 10.1002/alz.70537.
Alzheimers Dement. 2025.
PMID: 40937833
Free PMC article.
Clinical Trial.